Clerk of the House of Representatives
Legislative Resource Center
135 Cannon Building
Washington, DC 20515
http://lobbyingdisclosure.house.gov 		Secretary of the Senate
Office of Public Records
232 Hart Building
Washington, DC 20510
http://www.senate.gov/lobby

LOBBYING REGISTRATION

Lobbying Disclosure Act of 1995 (Section 4)

Check One: New Registrant New Client for Existing Registrant Amendment

1. Effective Date of Registration
4/1/2023
2. House Identification
 399030000
 Senate Identification
 40032268-12

REGISTRANT Organization/Lobbying Firm Self Employed Individual

3. Registrant Organization
Astellas Pharma US, Inc.
Address
2375 Waterview Drive
 Address2
​
City
Northbrook
 State
IL
 Zip
60062
 Country
USA

4. Principal place of business (if different than line 3)

City
​
State
​
Zip
​
Country
​
5. Contact name and telephone number International Number
Contact
​Mr. James Rollins
 Telephone
​5714719064
 E-mail
​james.rollins@astellas.com
6. General description of registrant’s business or activities
​Pharmaceuticals

CLIENT A Lobbying Firm is required to file a separate registration for each client. Organizations employing in-house lobbyists should check the box labeled “Self” and proceed to line 10. Self

7. Client name
​Astellas Pharma US, Inc.
Address
​
City
​
State
​
Zip
​
Country
​USA
8. Principal place of business (if different than line 7)
City
​
State
​
Zip
​
Country
​
9. General description of client’s business or activities
​

LOBBYISTS

10. Name of each individual who has acted or is expected to act as a lobbyist for the client identified on line 7. If any person listed in this section has served as a “covered executive branch official” or “covered legislative branch official” within twenty years of first acting as a lobbyist for the client, state the executive and/or legislative position(s) in which the person served.

Name Covered Official Position (if applicable)
First
Last
Suffix
​Jonathan ​Oehmen ​ ​Legislative Correspondent, Legislative Assistant, and Sr. Legislative Assistant for Rep. John Sullivan (OK Dist. 1); Legislative Director and then Chief of Staff for Rep. Bill Flores (TX Dist. 17).
​Akshai ​Datta ​ ​Sr. Legislative Assistant to Rep. Ami Bera (CA Dist. 7); Sr. Legislative Assistant to Rep. Bruce Braley (IA Dist. 1); Legislative Assistant and Legislative Correspondent to Rep. Leonard Boswell (IA Dist. 3).
​James ​Rollins ​ ​None
​ ​ ​ ​
​ ​ ​ ​

LOBBYING ISSUES

11. General lobbying issue areas (Select all applicable codes).

​MMM
​HCR
​CPT
​
​
​
​
​
​

12. Specific lobbying issues (current and anticipated)

Transparency Policy Issues, Medicare Part D, Coverage Gap, Rebate Reform, Out-of-Pocket Costs, International Reference Pricing, Oncology Screening Awareness, Value-based Payment Arrangements for Gene Therapy, (no specific bills). Value of Prescription Drugs, Drug pricing, Biopharmaceutical Innovation and Patient Policy Issues (no specific bills). Issues related to Patient Drug User Fee Reauthorization (no specific bills). Issues related to Bayh-Dole Act (Pub. L. 96-517).

AFFILIATED ORGANIZATIONS

13. Is there an entity other than the client that contributes more than $5,000 to the lobbying activities of the registrant in a quarterly period and either participates in and/or in whole or in major part supervises or controls the registrant’s lobbying activities?

No --> Go to line 14. Yes --> Complete the rest of this section for each entity matching the criteria above, then proceed to line 14.
Internet Address:
​
Name Address Principal Place of Business
Street
City State/Province Zip Code Country
​
​
City
​
​
​
​
​
State
​
Country
​
​
​
City
​
​
​
​
​
State
​
Country
​
​
​
City
​
​
​
​
​
State
​
Country
​

FOREIGN ENTITIES

14. Is there any foreign entity

a) holds at least 20% equitable ownership in the client or any organization identified on line 13; or

b) directly or indirectly, in whole or in major part, plans, supervises, controls, directs, finances or subsidizes activities of the client or any organization identified on line 13; or

c) is an affiliate of the client or any organization identified on line 13 and has a direct interest in the outcome of the lobbying activity?

No --> Sign and date the registration. Yes --> Complete the rest of this section for each entity matching the criteria above, then sign the registration.
Address Ownership
Name Street Principal place of business Amount of contribution
City State/Province Country
(city and state or country) for lobbying activities
​2-3-11, Nihonbashi-Honcho, Chuo-ku
City
​
​Astellas Pharma Inc. (through 100% ownership of Astellas US Holding, Inc.)
​Tokyo
​
​JPN
State
​
Country
​
​0
​100
 %
​
City
​
​
​
​
​
State
​
Country
​
​
​
%

CONVICTIONS DISCLOSURE

15. Have any of the lobbyists listed on this report been convicted in a Federal or State Court of an offense involving bribery, extortion, embezzlement, an illegal kickback, tax evasion, fraud, a conflict of interest, making a false statement, perjury, or money laundering?

Signature
Digitally Signed By: Joseph Devaney
 Date
4/10/2023 1:53:43 PM